Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 9, Issue 4, 2007, Pages

  Moonen, Jan Renier A J ^a   de Leeuw, Karina ^a   van Seijen, Xavier J Gallego Y ^a   Kallenberg, Cees G M ^a   van Luyn, Marja J A ^a   Bijl, Marc ^a   Harmsen, Martin C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CASPASE 8; CASPASE 8L; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; HYDROXYCHLOROQUINE; MATRIGEL; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; CASP8 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL DAMAGE; CELL FUNCTION; CELL MIGRATION; CIRCULATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL CULTURE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CELL CULTURE; CELL PROLIFERATION; CHEMOTAXIS; CLONOGENIC ASSAY; CYTOLOGY; ENZYMOLOGY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HEMATOPOIETIC STEM CELL; HOSPITALIZATION; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; APOPTOSIS; CASPASE 8; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COLONY-FORMING UNITS ASSAY; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 34948892057     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2283     Document Type: Article

References (42)

1. El Magadmi M Bodill H Ahmad Y Durrington PN Mackness M Walker M Bernstein RM Bruce IN Systemic lupus erythematosus: An independent risk factor for endothelial dysfunction in women Circulation 2004, 110:399:404 10.1161/01.CIR.0000136807.78534.50 15262847
2. Manzi S Meilahn EN Rairie JE Conte CG Medsger TA Jr Jansen-McWilliams L D'Agostino RB Kuller LH Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study Am J Epidemiol 1997, 145:408-415 9048514
3. Ward MM Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus Arthritis Rheum 1999, 42:338-346 10.1002/ 1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U 10025929
4. Asanuma Y Oeser A Shintani AK Turner E Olsen N Fazio S Linton MF Raggi P Stein CM Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 2003, 349:2407-2415 10.1056/NEJMoa035611 14681506
5. Roman MJ Shanker BA Davis A Lockshin MD Sammaritano L Simantov R Crow MK Schwartz JE Paget SA Devereux RB Salmon JE Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 2003, 349:2399-2406 10.1056/NEJMoa035471 14681505
6. Bruce IN Urowitz MB Gladman DD Ibanez D Steiner G Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study Arthritis Rheum 2003, 48:3159-3167 10.1002/ art.11296 14613278
7. de Leeuw K Freire B Smit AJ Bootsma H Kallenberg CG Bijl M Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus Lupus 2006, 15:675-682 10.1177/0961203306069972 17120595
8. Esdaile JM Abrahamowicz M Grodzicky T Li Y Panaritis C du Berger R Cote R Grover SA Fortin PR Clarke AE Senecal JL Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus Arthritis Rheum 2001, 44:2331-2337 10.1002/ 1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I 11665973
9. Ross R Atherosclerosis - an inflammatory disease N Engl J Med 1999, 340:115-126 10.1056/NEJM199901143400207 9887164
10. Asahara T Kawamoto A Endothelial progenitor cells for postnatal vasculogenesis Am J Physiol Cell Physiol 2004, 287:C572-C579 10.1152/ ajpcell.00330.2003 15308462
11. Rafii S Lyden D Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat Med 2003, 9:702-712 10.1038/ nm0603-702 12778169
12. Ingram DA Caplice NM Yoder MC Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells Blood 2005, 106:1525-1531 10.1182/blood-2005-04-1509 15905185
13. Urbich C Dimmeler S Endothelial progenitor cells: Characterization and role in vascular biology Circ Res 2004, 95:343-353 10.1161/ 01.RES.0000137877.89448.78 15321944
14. Bruce IN Atherogenesis and autoimmune disease: The model of lupus Lupus 2005, 14:687-690 10.1191/0961203305lu2201oa 16218468
15. Bombardier C Gladman DD Urowitz MB Caron D Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 1992, 35:630-640 10.1002/ art.1780350606 1599520
16. Tan EM Cohen AS Fries JF Masi AT McShane DJ Rothfield NF Schaller JG Talal N Winchester RJ The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982, 25:1271-1277 10.1002/art.1780251101 7138600
17. Hill JM Zalos G Halcox JP Schenke WH Waclawiw MA Quyyumi AA Finkel T Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 2003, 348:593-600 10.1056/NEJMoa022287 12584367
18. de Leeuw K Sanders JS Stegeman C Smit A Kallenberg CG Bijl M Accelerated atherosclerosis in patients with Wegener's granulomatosis Ann Rheum Dis 2005, 64:753-759 10.1136/ard.2004.029033 15374854
19. Gehling UM Ergun S Schumacher U Wagener C Pantel K Otte M Schuch G Schafhausen P Mende T Kilic N In vitro differentiation of endothelial cells from AC133-positive progenitor cells Blood 2000, 95:3106-3112 10807776
20. Peichev M Naiyer AJ Pereira D Zhu Z Lane WJ Williams M Oz MC Hicklin DJ Witte L Moore MA Rafii S Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 2000, 95:952-958 10648408
21. Shmelkov SV St Clair R Lyden D Rafii S C133/CD133/Prominin-1 Int J Biochem Cell Biol 2005, 37:715-719 10.1016/j.biocel.2004.08.010 15694831
22. Fernandez Pujol B Lucibello FC Gehling UM Lindemann K Weidner N Zuzarte ML Adamkiewicz J Elsasser HP Muller R Havemann K Endothelial-like cells derived from human CD14 positive monocytes Differentiation 2000, 65:287-300 10.1046/j.1432-0436.2000.6550287.x 10929208
23. Rehman J Li J Orschell CM March KL Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors Circulation 2003, 107:1164-1169 10.1161/ 01.CIR.0000058702.69484.A0 12615796
24. Arras M Ito WD Scholz D Winkler B Schaper J Schaper W Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb J Clin Invest 1998, 101:40-50 508538 9421464
25. Awad O Dedkov EI Jiao C Bloomer S Tomanek RJ Schatteman GC Differential healing activities of CD34+ and CD14+ endothelial cell progenitors Arterioscler Thromb Vasc Biol 2006, 26:758-764 10.1161/ 01.ATV.0000203513.29227.6f 16410458
26. Fujiyama S Amano K Uehira K Yoshida M Nishiwaki Y Nozawa Y Jin D Takai S Miyazaki M Egashira K Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells Circ Res 2003, 93:980-989 10.1161/01.RES.0000099245.08637.CE 14525810
27. Choi JH Kim KL Huh W Kim B Byun J Suh W Sung J Jeon ES Oh HY Kim DK Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure Arterioscler Thromb Vasc Biol 2004, 24:1246-1252 10.1161/01.ATV.0000133488.56221.4a 15155385
28. Grisar J Aletaha D Steiner CW Kapral T Steiner S Seidinger D Weigel G Schwarzinger I Wolozcszuk W Steiner G Smolen JS Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis Circulation 2005, 111:204 -211 10.1161/ 01.CIR.0000151875.21836.AE 15642766
29. Herbrig K Haensel S Oelschlaegel U Pistrosch F Foerster S Passauer J Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells Ann Rheum Dis 2006, 65:157-163 10.1136/ard.2005.035378 15975971
30. Westerweel PE Luijten RK Hoefer IE Koomans HA Derksen RH Verhaar MC Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus Ann Rheum Dis 2007, 66:865-870 10.1136/ard.2006.065631 17329307
31. Llevadot J Murasawa S Kureishi Y Uchida S Masuda H Kawamoto A Walsh K Isner JM Asahara T HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells J Clin Invest 2001, 108:399-405 209363 11489933 10.1172/JCI200113131
32. Dufour C Corcione A Svahn J Haupt R Poggi V Beka'ssy AN Scime R Pistorio A Pistoia V TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro Blood 2003, 102:2053-2059 10.1182/blood-2003-01-0114 12750172
33. Aringer M Feierl E Steiner G Stummvoll GH Hofler E Steiner CW Radda I Smole JS Graninger WB Increased bioactive TNF in human systemic lupus erythematosus: Associations with cell death Lupus 2002, 11:102-108 10.1191/0961203302lu160oa 11958572
34. Studnicka-Benke A Steiner G Petera P Smolen JS Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus Br J Rheumatol 1996, 35:1067-1074 10.1093/rheumatology/35.11.1067 8948291
35. Alvarado-de la Barrera C Alcocer-Varela J Richaud-Patin Y Alarcon-Segovia D Llorente L Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients Scand J Immunol 1998, 48:551-556 10.1046/ j.1365-3083.1998.00427.x 9822266
36. Nagafuji K Shibuya T Harada M Mizuno S Takenaka K Miyamoto T Okamura T Gondo H Niho Y Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood 1995, 86:883-889 7542501
37. Papadaki HA Boumpas DT Gibson FM Jayne DR Axford JS Gordon-Smith EC Marsh JC Eliopoulos GD Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus Br J Haematol 2001, 115:167-174 10.1046/ j.1365-2141.2001.03076.x 11722430
38. Horiuchi T Himeji D Tsukamoto H Harashima S Hashimura C Hayashi K Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes Biochem Biophys Res Commun 2000, 272:877-881 10.1006/bbrc.2000.2841 10860845
39. Himeji D Horiuchi T Tsukamoto H Hayashi K Watanabe T Harada M Characterization of caspase-8L: A novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade Blood 2002, 99:4070-4078 10.1182/blood.V99.11.4070 12010809
40. Mohr A Zwacka RM Jarmy G Buneker C Schrezenmeier H Dohner K Beltinger C Wiesneth M Debatin KM Stahnke K Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis Oncogene 2005, 24:2421-2429 10.1038/sj.onc.1208432 15735742
41. van Beem RT Noort WA Kleijer M van der Schoot CE Zwaginga JA Colony forming unit-endothelial cells (CFU-EC) are derived from CD14+ cells and are supported by CD14- cells [abstract] Vascular Pharmacol 2006, 45:e26-e27 10.1016/j.vph.2006.08.114
42. George J Shmilovich H Deutsch V Miller H Keren G Roth A Comparative analysis of methods for assessment of circulating endothelial progenitor cells Tissue Eng 2006, 12:331-335 10.1089/ten.2006.12.331 16548691